Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04266795
Title Triple Combination of Pevonedistat and Venetoclax Plus Azacitidine in Adults With Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Takeda

acute myeloid leukemia


Azacitidine + Venetoclax

Azacitidine + MLN4924 + Venetoclax

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | CAN

No variant requirements are available.